S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures
(2011)
Journal Article
Sphingosine-1-phosphate receptors (S1PRs) are drug targets for the compound FTY720, which is the first oral therapy developed for treatment of relapsing-remitting multiple sclerosis. S1PRs play a variety of functional roles in the differentiation, pr... Read More about S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.